drugset / Trial / NCT02045264
Open-label, Single-arm Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of Icatibant in Healthy Japanese Volunteers
NaSingle-groupOpen-labelTreatment
Summary
This is a single-dose study to evaluate the pharmacokinetics, safety, and tolerability of icatibant administered to adult Japanese subjects.
Timeline
- Start
- 2014-02-21
- Primary completion
- 2014-02-27
- Completion
- 2014-02-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Icatibant | Peptide | 30 mg | Subcutaneous |